Last Update:
January 27, 2012
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
Journal
Papers, Abstracts, and Commentaries
| |
|
HIV infection and bone disease: implications
for an aging population.
Cotter AG, Mallon PW.
Sex Health. 2011 Nov;8(4):493-501.
Abstract
HIV and bone metabolism.
Ofotokun I, Weitzmann MN.
Discov Med.
2011 May;11(60):385-93
Abstract
The Role of HIV and Antiretroviral Therapy in
Bone Disease.
Gutiérrez F, Masiá M.
AIDS Rev.
2011 Apr-Jun;13(2):109-18.
Abstract
Low CD4 Count is Associated with an Increased
Risk of Fragility Fracture in HIV-infected Patients.
Yong MK, Elliott JH, Woolley IJ, Hoy JF.
J Acquir Immune Defic Syndr.
2011 Apr 23
Abstract
Markers of bone turnover are elevated in patients
with antiretroviral treatment independent of the substance used.
Piso RJ, Rothen M, Rothen JP, Stahl M.
J Acquir Immune Defic Syndr.
2011 Apr;56(4):320-4.
Abstract
Alveolar Granulocytic Sarcoma of the Mandible in a
Patient with HIV.
Colović N, Jurišić V, Terzić T,
et al
Onkologie.
2011;34(1-2):55-8.|
Abstract
Prospective one-year bone loss in treatment-naďve HIV+ men and
women on single or multiple
drug HIV therapies.
Briot K, Kolta S, Flandre P,
et
al
Bone.
2011 Jan 26
Abstract
Bone Disease in HIV Infection: A Practical Review and
Recommendations for HIV Care
Providers.
McComsey GA, Tebas P, Shane E, et al
Clin Infect Dis.
2010 Sep 14
Abstract |
HIV and Bone Loss.
Arora S, Agrawal M, Sun L, et al
Curr Osteoporos Rep.
2010 Sep 10.
Abstract |
|
|
HIV and Bone Disease.
Stone B, Dockrell D, Bowman C, McCloskey E.
Arch Biochem Biophys.
2010 Jul 31
Abstract |
Bone Changes and Fracture Risk in Individuals
Infected With HIV.
Warriner AH, Mugavero MJ .
Curr Rheumatol Rep.
2010 Apr 28.
Abstract
|
HIV-Induced Abnormalities in Myelopoiesis and their
Recovery
Following Antiretroviral Therapy.
Andrea C, Simona G, Luca B, et al
Curr HIV Res.
2010 Mar 19.
Abstract |
FULL-TEXT ARTICLE
Operations about Hip in Human Immunodeficiency
Virus-Positive Patients..
Yoo JJ, Chun SH, Kwon YS,
et al
Clin Orthop Surg.
2010 Mar;2(1):22-7.
Paper |
Short-Term Bone Loss in HIV-Infected Premenopausal
Women.
Yin MT, Lu D, Cremers S, Tien PC, et al
J Acquir Immune Defic Syndr.
2009 Nov 3.
Abstract |
Bone health in HIV infection.
Pollock E, Klotsas AE, Compston J, Gkrania-Klotsas E.
Br Med Bull.
2009 Oct 29.
Abstract |
Rheumatic manifestations associated with HIV in the highly active
antiretroviral therapy era.
Nguyen BY, Reveille JD.
Curr Opin Rheumatol.
2009 May 12
Abstract |
Digital Clubbing in HIV-Infected Patients: An Observational
Study.
Dever LL, Matta JS.
AIDS Patient Care STDS.
2008 Dec 2.
Abstract
|
Total joint arthroplasty in human immunodeficiency
virus-positive
patients: An alarming
rate of early failure.
Parvizi J, Sullivan TA, Pagnano MW, et al.
J Arthroplasty 2003 Apr;18(3):259-64
Abstract
FULL-TEXT ARTICLE
Emerging bone problems in patients infected with human
immunodeficiency virus.
Mondy K, Tebas P.
Clin Infect Dis 2003 Apr 1;36(Suppl 2):S101-5
Paper
Reduced intravertebral bone marrow fat in HIV-infected men.
Huang JS, Mulkern RV, Grinspoon S.
AIDS 2002 Jun 14;16(9):1265-9
Abstract
|
|
Conference
Reports, Abstracts, and Posters
|
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and
Commentaries
| |
HIV-1, HAART and bone metabolism.
Borderi M, Farneti B, Tampellini L, et
al.
New Microbiol 2002
Jul;25(3):375-84
Abstract
Rheumatological complications associated with the use of indinavir and other
protease inhibitors.
Florence E, Schrooten W, Verdonck K, et
al.
Ann Rheum Dis 2002 Jan;61(1):82-4
Abstract
FULL-TEXT ARTICLE
Decreased Bone Formative and Enhanced Resorptive Markers in Human
Immunodeficiency
Virus Infection: Indication of Normalization of the Bone-Remodeling
Process
during Highly
Active
Antiretroviral Therapy
Aukrust P, Haug CJ, Ueland T, et al.
J Clin Endocrinol. Metab 1999
84: 145-150
Paper |
|
Conference Reports, Abstracts, and
Posters
Journal Papers, Abstracts, and
Commentaries
| |
Stable Bone Density in HAART-Treated
Individuals with HIV: A Metaanalysis.
Bolland MJ, Wang TK, Grey A, et al
J Clin Endocrinol Metab.
2011 Jun 29.
Abstract
Comparison of Changes in Bone Density and Turnover with
Abacavir-Lamivudine
versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results
from the
ASSERT Study.
Stellbrink HJ, Orkin C, Arribas JR, et al
Clin Infect Dis.
2010 Sep
Abstract
Bone mineral density changes in protease inhibitor-sparing
vs. nucleoside reverse
transcriptase inhibitor-sparing highly active antiretroviral
therapy: data from a
randomized trial.
Hansen A, Obel N, Nielsen H, et
al
HIV Med.
2010 Aug 15.
Abstract
High prevalence of and progression to low bone mineral
density in HIV-infected patients: "
a longitudinal cohort study.
Bonjoch A, Figueras M, Estany C, et al
AIDS.
2010 Oct 31
Abstract |
Hypovitaminosis D and Bone Mineral Density in HIV infected Indian
Men
with or without antiretroviral therapy.
Paul TV, Asha HS, Thomas N,
et al
Endocr Pract.
2010 Feb 11:1-21.
Abstract |
Low Bone Mineral Density, Renal Dysfunction, and Fracture Risk in
HIV Infection:
A Cross-Sectional Study.
Calmy A, Fux CA, Norris R, Vallier N,
et al
J Infect Dis. 2009 Oct 29.
Abstract |
Loss of Bone Mineral Density After Antiretroviral Therapy
Initiation, Independent of
Antiretroviral Regimen.
Brown TT, McComsey GA, King MS,
et al
J Acquir Immune Defic Syndr.
2009 Jun 8.
Abstract |
Greater decrease in bone mineral density with protease inhibitor regimens
compared with
nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive
patients.
Duvivier C, Kolta S, Assoumou L, et al
AIDS. 2009 Apr 27;27(7):817-24.
Abstract |
Reduced bone mineral density in HIV-infected patients: prevalence and
associated factors.
Cazanave C, Dupon M, Lavignolle-Aurillac V, et al
AIDS. 2008 Jan 30;22(3):395-402.
Abstract
|
FULL-TEXT ARTICLE
How does it work?: Bone
mineral density scans
Berger A
BMJ 2002;325 484
Paper
Increased abdominal visceral fat is associated with reduced bone
density in HIV-infected
men with lipodystrophy.
Huang JS, Rietschel P, Hadigan CM, et al.
AIDS 2001 May 25;15(8):975-82
Abstract |
|
Conference Reports, Abstracts, and
Posters
| |
POSTER
Universal assessment of bone mass density is cost-effective in HIV-positive
patients at any time during follow-up
E. Mazzotta, T. Ursini, F. Vadini, et al
(6th IAS
Conference)
Abstract
Poster
Changes in bone
mineral density after 96 weeks of treatment with tenofovir DF/emtricitabine
plus atazanavir/ritonavir or lopinavir/ritonavir in HIV-1 infected treatment
naďve subjects: the CASTLE body composition sub-study
G. Moyle, D. Ward, A. Farajallah, et al
(6th IAS
Conference)
Abstract
Prevalence and
determinants of reduced bone mineral density and treatment for osteoporosis in
HIV-infected patients in Montréal
M. Durand, H. Morin, C. Daoust, et al
(6th IAS
Conference)
Abstract
POSTER
A 48-week Randomized Study of Uridine
Supplementation vs Switch to TDF on Limb Fat,
Mitochondrial Function, Inflammation, and Bone Mineral Density in HIV
Lipoatrophy
G McComsey M A O’Riordan, J Choi,
et al
(17th CROI)
PDF Poster
Abstract
|
Uridine
Supplementation in the Management of HIV Lipoatrophy: Results of ACTG 5229
G McComsey, U
Walker, C Budhathoki
(17th CROI
Abstract |
POSTER
Bone Mineral Density 96 Weeks
after ART Initiation: A Randomized Trial Comparing Efavirenz-based
Therapy with aLopinavir/Ritonavir-containing Regimen with Simplification to
LPV/r Monotherapy
T Brown, G McComsey M King, et al
(16 CROI)
PDF Poster
Abstract
|
POSTER
Effect of HIV on Menstrual Patterns and Bone Mineral Density
G Gopalakrishnan, A
Howard, N Budner, et al
(13 CROI
PDF Poster
Abstract |
POSTER
Factors Associated with Reduced Bone Mineral Density in HIV-infected
Patients;
ANRS CO 3 Aquitaine Cohort, France
H Dutronc, V Lavignolle-Aurilla, R Thiebaut,
et al
(13 CROI)
PDF Poster
Abstract |
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and
Commentaries
Conference Reports, Abstracts, and
Posters
| |
Incidence and Predictors of Fracture in
HIV-infected Individuals: ALLRT
M Yin, M Kendall, X Wu, et al
(18th CROI)
Abstract
HIV-infection and Fragility Fracture Risk among Male Veterans
J Womack, J Goulet, C
Gibert, et al
(17th CROI)
Abstract
|
Higher and
Increasing Rates of Fracture among HIV-infected Persons in the HIV
Outpatient Study Compared to the General US Population, 1994 to 2008
C Dao, B Young, K Buchacz, et al
(17th CROI)
Abstract |
Bone Fracture (FX) Rates In HIV + Patients Receiving PI Vs Non-PI Regimens
(41 ICAAC)
Abstract |
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and
Commentaries
| |
Longitudinal evolution of bone mineral density and bone markers in human
immunodeficiency virus-infected individuals.
Mondy K, Yarasheski K, Powderly WG, et al.
Clin Infect Dis 2003 Feb 15;36(4):482-90
Abstract
Osteopenia in patients infected by the human immunodeficiency virus. A case
control
study.
Loiseau-Peres S, Delaunay C, Poupon S, et al
Joint Bone Spine 2002 Oct;69(5):482-5
Abstract
Osteopenia in HIV-infected patients: is it the disease or is it the
treatment?
Knobel H, Guelar A, Vallecillo G, et al
AIDS 2001 Apr 13;15(6):807-8
Abstract
FULL-TEXT ARTICLE
Osteopenia
in eugonadal men with acquired immune deficiencysyndrome wasting
syndrome.
Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK. et al.
J Clin Endocrinol Metab 2001
May;86(5):2020-6
Paper
Osteopenia in HIV-infected men: association with asymptomatic
lactic acidemia and
lower weight pre-antiretroviral therapy.
Carr A, Miller J, Eisman JA, Cooper DA.
AIDS 2001 Apr 13;15(6):703-9
Abstract
|
|
Journal Papers, Abstracts, and
Commentaries
Conference Reports, Abstracts, and Posters
|
| |
POSTER
Cardiovascular risk and osteoporosis are associated in HIV-infected
patients, ANRS CO3 Aquitaine Cohort, France
N. Mehsen, S. Lawson-Ayayi, T. Schaeverbeke,et al
(6th IAS Conference)
Abstract
Poster
The use of
calcaneal stiffness index to screen for osteoporosis in HIV-infected
individuals
A. Scourfield, L. Waters, A. Jackson, A. et al
(6th IAS Conference)
Abstract
Does antiretroviral therapy cause osteopaenia and
osteoporosis?
Nawale S, Chandanwale A, Giripunje N , Jadhav S
(4th IAS Conference)
Abstract |
Journal Papers, Abstracts, and
Commentaries
| |
Osteonecrosis in HIV-infected patients and its correlation with highly
active antiretroviral
therapy (HAART)
Calza L, Manfredi R, Chiodo F.
Presse Med 2003 Apr 5;32(13 Pt
1):595-8
Abstract
Avascular Necrosis in HIV-Infected Patients Receiving
Antiretroviral
Treatment: Study of
Seven Cases.
Valencia ME, Barreiro P, Soriano V, et al
HIV Clin Trials 2003 Mar-Apr;4(2):132-136
Abstract
Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical
management.
Allison GT, Bostrom MP, Glesby MJ.
AIDS
2003 Jan 3;17(1):1-9
Abstract
Association between human immunodeficiency virus and
osteonecrosis of the femoral head.
Ries MD, Barcohana B, Davidson A, et al.
J Arthroplasty 2002 Feb;17(2):135-9
Abstract
|
|
|
HIV
Musculoskeletal Main Page
